Down-regulation of Hsp27 radiosensitizes human prostate cancer cells

Shahram Teimourian1, Razieh Jalal, Mostafa Sohrabpour

  • 1Laboratory of Biophysics and Molecular Biology, Institute of Biophysics and Biochemistry, University of Tehran, Iran.

Abstract

Insights

Reducing heat shock protein 27 (Hsp27) levels in prostate cancer cells significantly increased their sensitivity to gamma radiation. This suggests Hsp27 may be a target for enhancing radiation therapy effectiveness.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Heat shock protein 27 (Hsp27) is a small heat shock protein known to inhibit apoptosis.
  • Hsp27 plays a role in cellular stress responses and survival.

Purpose of the Study:

  • To investigate the role of human Hsp27 in gamma radiation-induced sensitization of human prostate cancer cells.
  • To determine if reducing Hsp27 expression can enhance the efficacy of radiation therapy.

Main Methods:

  • Human prostate cancer cells (DU145) were transfected with full-length Hsp27 antisense cDNA.
  • Western blot analysis was used to confirm reduced Hsp27 expression in selected clones.
  • Colony formation assays were performed to assess radiation sensitivity.

Main Results:

  • Cells engineered to express reduced Hsp27 levels exhibited significantly increased sensitivity to gamma radiation compared to control cells.
  • A significant difference in cell viability was observed between reduced Hsp27 and control groups 72 hours post-irradiation.

Conclusions:

  • Reduced Hsp27 expression enhances prostate cancer cell sensitivity to gamma radiation.
  • Antisense Hsp27 cDNA or similar strategies targeting Hsp27 could be valuable as radiosensitizers in radiation oncology.